Spinal Muscular Atrophy (SMA) is an autosomal recessive neurodegenerative disease, and the most common cause of mortality in infants linked to a genetic mutation.
In this Spinal Muscular Atrophy Support UK video, watch SMA patient Suzanne talk about her experience in high school, how she made the decision to go to university, and to get a car of her own–all while dealing with a disease that affects between 1 in 6,000 to 10,000 people.
Research is key to improve both life expectancy and quality of life for patients. Recently, progress reports on six treatment options for SMA, all currently in clinical trials, were spotlighted at the 2016 Annual SMA Conference in Anaheim, CA.
SMA News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.